Opens in a new tab

Edwards Lifesciences v Meril (CFI, 29 September 2023)

Date29 September 2023
CourtCFI
DivisionMunich (DE) Local Division
Type of actionInfringement Action
Case number(s)UPC_CFI_15/2023
Registry referenceORD_576853/2023 · UPC_CFI_15/2023
PartiesEdwards Lifesciences Corporation v. Meril GmbH

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 29 September 2023 (ORD_576853/2023, UPC_CFI_15/2023), the judge-rapporteur of the Munich Local Division deferred to the main proceedings the preliminary objection lodged by Meril GmbH and Meril Life Sciences in Edwards Lifesciences’ infringement action on EP 3 646 825, declined to stay the proceedings for the time being, dismissed the application for security for costs and requested the assignment of a technically qualified judge. The judge-rapporteur already gives his view on jurisdiction over acts before 1 June 2023.

Question

Should the jurisdictional challenges, the request for a stay and a CJEU referral, and the application for security for costs against a US-based claimant be decided at this stage?

Decision

The objection, wrongly filed in the statement of defence workflow, was not held inadmissible given that the system was new (Rule 4.1 RoP). The concern about extension to future ratifying states was hypothetical. The argument excluding acts before 1 June 2023 was considered legally wrong in light of Arts 3(c) and 32(1)(a) UPCA. Since the claim targets the teaching of the patent as a whole, the Munich division has competence over Meril GmbH, based in Bonn, and over its Indian parent under the second sentence of Art. 33(1)(b) UPCA, given their commercial relationship. A stay and a referral are not among the grounds listed in Rule 19.1 RoP and will be reconsidered in the main proceedings. Security for costs (Art. 69(4) UPCA, Rule 158.1 RoP) requires a showing of financial weakness or particular difficulty of enforcement. Mere uncertainty about recognition in the United States is not enough.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 3(c), 8(5), 32(1)(a), 33(1)(b) and 69(4)
Rules of Procedure
Rules 4.1, 19.1, 20.2 and 158.1

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Patent infringement action.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_15/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 1 August 2023 Edwards Lifesciences v Meril (CFI, 1 August 2023) Infringement Action · UPC_CFI_15/2023
  2. 10 August 2023 Meril v Edwards Lifesciences (CFI, 10 August 2023) Infringement Action · UPC_CFI_15/2023

    Le juge rapporteur proroge au 4 septembre 2023 le délai d'exception préliminaire de Meril GmbH, à titre exceptionnel et avec l'accord d'Edwards, congés et charge de travail n'étant pas des motifs suffisants.

  3. 23 August 2023 Edwards Lifesciences v Meril (CFI, 23 August 2023) Infringement Action · UPC_CFI_15/2023

    Le juge rapporteur proroge au 2 novembre 2023 le délai de défense de Meril GmbH, à titre exceptionnel et avec l'accord d'Edwards, l'alignement des délais n'étant pas en soi un motif de prorogation.

  4. 29 September 2023 Edwards Lifesciences v Meril (CFI, 29 September 2023) Infringement Action · UPC_CFI_15/2023
  5. 5 May 2025 Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) Decision By Default · appeal, first-instance number cited in the decision

    La cour d’appel annule l’ordonnance d’accès et rejette la demande : un membre du public non représenté ne peut obtenir l’accès de la règle 262.1(b), et aucun frais n’est alloué dans cette procédure.

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
Le juge rapporteur joint l'exception préliminaire au fond, refuse en l'état le sursis, rejette la demande de garantie des frais visant une demanderesse américaine et demande l'adjonction d'un juge technicien.
Appeal
An appeal is documented in the corpus (see above).
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.